| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() Vaxigrip And Fluzone Flu Vaccines Not Associated With Reported Adverse Events In Canada TORONTO, ON -- November 8, 2000 -- Health Canada has advised Aventis Pasteur Limited and provincial health authorities that since October, the vaccine surveillance system has received reports of 117 mild adverse events (red eyes and respiratory symptoms that disappeared in 48 hours) following flu shots administered in British Columbia, Manitoba, Newfoundland, Alberta, and Quebec. Aventis Pasteur Limited confirms that its influenza vaccines, Vaxigrip® and Fluzone®, are not distributed to provincial immunization programs in the above-mentioned provinces and are not associated with these adverse events. Aventis Pasteur Limited, Canada's largest distributor of influenza vaccine, has contracted to supply 8.3 million doses of vaccines through provincial immunization programs in Ontario, Nova Scotia, New Brunswick, Saskatchewan, Nunavut and the North West Territories. Another manufacturer distributes flu vaccine to provincial immunization programs in the remaining provinces and territory. Following the distribution of over five million doses of Aventis Pasteur flu vaccines so far this year in Canada, and tens of millions of doses in the United States and throughout the world, none of these adverse events confirmed by Health Canada have been observed following administration of Vaxigrip® or Fluzone®. Canadians at risk for influenza are encouraged to be vaccinated to effectively prevent this disease. While the vast majority of people have no side-effects after receiving a flu shot, some may experience minor pain or swelling at the injection site. A few may experience mild fever and achiness within 24 to 48 hours of receiving their shot. Influenza is a serious and life-threatening illness. The risk of disease far outweighs the risk associated with immunization. Related Link: Aventis Pasteur Limited.
|